Cyclerion Therapeutics, Inc.
Phosphorus prodrugs of pyrazolo-substituted pyrimidine sGC stimulators

Last updated:

Abstract:

The present patent application discloses the compounds according to Formula (I) shown below, or pharmaceutically acceptable salts thereof wherein J.sup.B, n, R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, m and X as defined herein. ##STR00001##

Status:
Grant
Type:

Utility

Filling date:

6 Jul 2017

Issue date:

23 Feb 2021